Checkpoint inhibitor immunotherapy in kidney cancer von Xu, Wenxin, Atkins, Michael B., McDermott, David F.

Volltext

Toxicities of Immunotherapy for the Practitioner von Weber, Jeffrey S, Yang, James C, Atkins, Michael B, Disis, Mary L

Volltext

Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade von Motzer, Robert J., Banchereau, Romain, Hamidi, Habib, Powles, Thomas, McDermott, David, Atkins, Michael B., Escudier, Bernard, Liu, Li-Fen, Leng, Ning, Abbas, Alexander R., Fan, Jinzhen, Koeppen, Hartmut, Lin, Jennifer, Carroll, Susheela, Hashimoto, Kenji, Mariathasan, Sanjeev, Green, Marjorie, Tayama, Darren, Hegde, Priti S., Schiff, Christina, Huseni, Mahrukh A., Rini, Brian

Volltext

PD‐1 as a potential target in cancer therapy von McDermott, David F., Atkins, Michael B.

Volltext

Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial von Haas, Naomi B, Dr, Manola, Judith, MS, Uzzo, Robert G, Prof, Flaherty, Keith T, MD, Wood, Christopher G, Prof, Kane, Christopher, Prof, Jewett, Michael, Prof, Dutcher, Janice P, Prof, Atkins, Michael B, Prof, Pins, Michael, Prof, Wilding, George, Prof, Cella, David, Prof, Wagner, Lynne, Prof, Matin, Surena, Prof, Kuzel, Timothy M, Prof, Sexton, Wade J, Prof, Wong, Yu-Ning, MD, Choueiri, Toni K, MD, Pili, Roberto, Prof, Puzanov, Igor, MD, Kohli, Manish, MD, Stadler, Walter, Prof, Carducci, Michael, Prof, Coomes, Robert, DiPaola, Robert S, Prof

Volltext

Avoiding Severe Toxicity From Combined BRAF Inhibitor and Radiation Treatment: Consensus Guidelines from the Eastern Cooperative Oncology Group (ECOG) von Anker, Christopher J., MD, Grossmann, Kenneth F., MD, PhD, Atkins, Michael B., MD, Suneja, Gita, MD, Tarhini, Ahmad A., MD, PhD, Kirkwood, John M., MD

Volltext

The efficacy of anti‐PD‐1 agents in acral and mucosal melanoma von Shoushtari, Alexander N., Munhoz, Rodrigo R., Kuk, Deborah, Ott, Patrick A., Johnson, Douglas B., Tsai, Katy K., Rapisuwon, Suthee, Eroglu, Zeynep, Sullivan, Ryan J., Luke, Jason J., Gangadhar, Tara C., Salama, April K. S., Clark, Varina, Burias, Clare, Puzanov, Igor, Atkins, Michael B., Algazi, Alain P., Ribas, Antoni, Wolchok, Jedd D., Postow, Michael A.

Volltext

Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer von Topalian, Suzanne L, Hodi, F. Stephen, Brahmer, Julie R, Gettinger, Scott N, Smith, David C, McDermott, David F, Powderly, John D, Carvajal, Richard D, Sosman, Jeffrey A, Atkins, Michael B, Leming, Philip D, Spigel, David R, Antonia, Scott J, Horn, Leora, Drake, Charles G, Pardoll, Drew M, Chen, Lieping, Sharfman, William H, Anders, Robert A, Taube, Janis M, McMiller, Tracee L, Xu, Haiying, Korman, Alan J, Jure-Kunkel, Maria, Agrawal, Shruti, McDonald, Daniel, Kollia, Georgia D, Gupta, Ashok, Wigginton, Jon M, Sznol, Mario

Volltext

YAP/TAZ Inhibition Induces Metabolic and Signaling Rewiring Resulting in Targetable Vulnerabilities in NF2-Deficient Tumor Cells von White, Shannon M., Avantaggiati, Maria Laura, Nemazanyy, Ivan, Di Poto, Cristina, Yang, Yang, Pende, Mario, Gibney, Geoffrey T., Ressom, Habtom W., Field, Jeffery, Atkins, Michael B., Yi, Chunling

Volltext

Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Mult... von HENG, Daniel Y. C, WANLING XIE, VENNER, Peter, KNOX, Jennifer J, CHI, Kim N, KOLLMANNSBERGER, Christian, MCDERMOTT, David F, OH, William K, ATKINS, Michael B, BUKOWSKI, Ronald M, RINI, Brian I, CHOUEIRI, Toni K, REGAN, Meredith M, WARREN, Mark A, ALI REZA GOLSHAYAN, SAHI, Chakshu, EIGL, Bernhard J, RUETHER, J. Dean, CHENG, Tina, NORTH, Scott

Volltext

Evolving impact of long-term survival results on metastatic melanoma treatment von Michielin, Olivier, Atkins, Michael B, Koon, Henry B, Dummer, Reinhard, Ascierto, Paolo Antonio

Volltext

Safety and efficacy of immune checkpoint inhibitors (ICIs) in cancer patients with HIV, hepatitis B, or hepatitis C viral infection von Shah, Neil J., Al-Shbool, Ghassan, Blackburn, Matthew, Cook, Michael, Belouali, Anas, Liu, Stephen V., Madhavan, Subha, He, Aiwu Ruth, Atkins, Michael B., Gibney, Geoffrey T., Kim, Chul

Volltext

Differential Expression of PD-L1 between Primary and Metastatic Sites in Clear-Cell Renal Cell Carcinoma von Callea, Marcella, Albiges, Laurence, Gupta, Mamta, Cheng, Su-Chun, Genega, Elizabeth M, Fay, André P, Song, Jiaxi, Carvo, Ingrid, Bhatt, Rupal S, Atkins, Michael B, Hodi, F Stephen, Choueiri, Toni K, McDermott, David F, Freeman, Gordon J, Signoretti, Sabina

Volltext

Cytokine-Based Therapy and Biochemotherapy for Advanced Melanoma von Atkins, Michael B

Volltext

Anti-S1P Antibody as a Novel Therapeutic Strategy for VEGFR TKI-Resistant Renal Cancer von Zhang, Liang, Wang, Xiaoen, Bullock, Andrea J, Callea, Marcella, Shah, Harleen, Song, Jiaxi, Moreno, Kelli, Visentin, Barbara, Deutschman, Douglas, Alsop, David C, Atkins, Michael B, Mier, James W, Signoretti, Sabina, Bhasin, Manoj, Sabbadini, Roger A, Bhatt, Rupal S

Volltext

Resistance of renal cell carcinoma to sorafenib is mediated by potentially reversible gene expression von Zhang, Liang, Bhasin, Manoj, Schor-Bardach, Rachel, Wang, Xiaoen, Collins, Michael P, Panka, David, Putheti, Prabhakar, Signoretti, Sabina, Alsop, David C, Libermann, Towia, Atkins, Michael B, Mier, James W, Goldberg, S Nahum, Bhatt, Rupal S

Volltext

Immunotherapy Combined or Sequenced With Targeted Therapy in the Treatment of Solid Tumors: Current Perspectives von Atkins, Michael B, Larkin, James

Volltext

Randomized Phase II Study of Multiple Dose Levels of CCI-779, a Novel Mammalian Target of Rapamycin Kinase Inhibitor, in Patients With Advanced Refractory Renal Cell Carcinoma von ATKINS, Michael B, HIDALGO, Manuel, DUKART, Gary, SHERMAN, Matthew L, STADLER, Walter M, LOGAN, Theodore F, DUTCHER, Janice P, HUDES, Gary R, PARK, Young, LIOU, Song-Heng, MARSHALL, Bonnie, BONI, Joseph P

Volltext

Navigating and adapting care integrating immunotherapy, antiangiogenic therapy, and combinations in patients with advanced renal cell carcinoma von Rini, Brian I, Brugarolas, James, Atkins, Michael B

Volltext

Cancer Immunotherapy: Past Progress and Future Directions von Atkins, Michael B., MD, Sznol, Mario, MD

Volltext